Psychiatric symptoms and behavioral disturbances in dementia: A review of therapy

International Psychogeriatrics

Volumn 8, Issue SUPPL. 2, 1996, Pages 201-207

  Burns, Alistair ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOPHENAZINE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; PINDOLOL; SELEGILINE; THIORIDAZINE; TRIFLUOPERAZINE; VALPROIC ACID;

AGGRESSION; AGITATION; ANXIETY; BEHAVIOR DISORDER; CHEMOPROPHYLAXIS; DEMENTIA; GERONTOPSYCHIATRY; HUMAN; MOOD; NURSING HOME; REVIEW; SIDE EFFECT; SYMPTOM;

BEHAVIOR THERAPY; DEMENTIA; HUMANS;

EID: 0030437789     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610297003359     Document Type: Review

References (13)

1. Allen, N., Gordon, S., Hope, T., & Burns, A. (1996). Mousepad. British Journal of Psychiatry, 169, 293-307.
2. Allen, R. L., Walker, Z., D'Ath, P. J. D., & Katona, C. L. E. (1995). Risperidone for psychotic and behavioural symptoms in Lewy body dementia. Lancet, 346, 185.
3. Burns, A. (1994). Treatment of noncognitive features of dementia. In R. Levy, R. Howard, & A. Burns (Eds.), Treatment and care in old age psychiatry. Petersfield, UK: Wrightson Biomedical.
4. Byrne, E. (1991). Nottingham group for the study of neurodegenerative disorder. Diagnostic criteria for dementia associated with Lewy bodies. Dementia, 2, 283-284.
5. Cohen-Mansfield, J., & Billig, N. (1986). Agitated behaviors in the elderly: 1. A conceptual review. Journal of the American Geriatrics Society, 34, 711-721.
6. Committee on the Safety of Medicines. (1994). Neuroleptic sensitivity in patients with dementia. Current Problems in Pharmacovigilance, 20(6).
7. Finkel, S.L., Lyons, J.S., Anderson, R.L., Sherrell, K., Davis, J., et al. (1995). Arandomized, placebo-controlled trial of thiothixene in agitated, demented nursing home patients. International Journal of Geriatric Psychiatry, 10, 129-136.
8. Goad, D., Davis, C., Liem, D., Fuselier, C., McCormack, J., et al. (1991). The use of Selegiline in Alzheimer's patients with behavior problems. Journal of Clinical Psychiatry, 52, 342-345.
9. Gottlieb, G. L., McAllister, T. W., & Gur, R. C. (1988). Depot neuroleptics in the treatment of behavioral disorders in patients with Alzheimer's disease. Journal of the American Geriatrics Society, 36, 619-621.
10. Greendyke, R. M., Elerkner, J. P., Webster, J. C., & Gulya, A. (1989). Treatment of behavioral problems with pindolol. Psychosomatics, 30, 161-165.
11. Greendyke, R. M., & Kanter, D. R. (1986). Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: A double blind study. Journal of Clinical Psychiatry, 47, 423-426.
12. Tariot, P. N., Erb, R., Leibovici, A., Podgorski, C. A., Cox, C., et al. (1994). Carbamazepine treatment of agitation in nursing home patients with dementia: A preliminary study. Journal of the American Geriatrics Society, 42, 1160-1166.
13. Tingle, D. (1986). Trazodone in dementia. Journal of Clinical Psychiatry, 47, 482.